Terms and Conditions

Terms and Conditions

Introduction

Welcome to this site (“Site”). ESTABLISHMENT LABS Holdings Inc. (referred to as “ESTABLISHMENT LABS”, “we”, “us” or “our”, as applicable) provides you with access to the Site subject to the terms and conditions contained in this Terms of Use Agreement (the “Agreement”). Please read this Agreement carefully. By accessing or using this Site, you agree without restriction to be bound by this Agreement. If you do not agree to follow and be bound by this Agreement, you may not access, use or download materials from this Site.

Please note that if you are an existing customer or supplier of ESTABLISHMENT LABS, these terms are not intended to replace or modify those contained in your customer or vendor agreement. In case of an inconsistency, the terms and conditions of your written agreement will prevail over those contained herein. All ESTABLISHMENT LABS products and services may also be subject to separate terms and conditions that govern their use.

ESTABLISHMENT LABS reserves the right to update or modify this Agreement at any time without prior notice. Your use of this Site following any such change constitutes your agreement to follow and be bound by this Agreement as revised. For this reason, we encourage you to review this Agreement each time you use this Site. This Agreement was last revised on 30 November 2022.

 

The Availability of the Site and International Users

The Site is administered by ESTABLISHMENT LABS Holdings Inc., and its contents (the “Content”) are designed to comply with local applicable laws and regulations. Access to the Site and the Content may not be legal by certain persons or in certain countries. If you access this Site from outside the United States, you do so at your own risk and are responsible for compliance with the laws of your jurisdiction. Materials published on this Site may refer to products or services that are not available in your country. Consult your local ESTABLISHMENT LABS office for more information. Furthermore, ESTABLISHMENT LABS makes no representation that the materials on the Site are appropriate or available for use at other locations outside the United States, and access to them from countries where their contents are illegal is prohibited. You should not construe anything on the Site as a promotion or solicitation for any product or for the use of any product that is not authorised by the laws and regulations of the country in which you are located

 

This Site is Not a Source of Medical Advice

The Content of this Site is presented in summary form, is general in nature, and is provided for informational purposes only; it is neither intended nor recommended as a substitute for professional medical advice. You should not use the Content of this Site for diagnosing a health/fitness problem or disease, or as a recommendation. Always seek the advice of your physician or other qualified health provider regarding any medical condition or treatment. Nothing contained on this Site is intended to be for medical advice. Never disregard medical advice or delay in seeking it because of something you have read on this Site.

 

Copyright Notice and Limitation on Use

No use should be made of materials on this Site, except as expressly authorised by this Agreement. All Site Content, including the selection, arrangement and design of the Content is owned either by ESTABLISHMENT LABS or its licensors and is protected by copyright and other intellectual property laws, including the sui generis rights relating to the protection of databases. You may not modify, copy, reproduce, republish, upload, post, transmit or distribute in any way any Content, in whole or in part, including any code and software. You may download Content from the Site for your own personal, non-commercial use only, provided that the Content is not modified in any way, you keep intact all copyright and other proprietary notices and you include the phrase, “Used with permission of Establishment Labs” when you display or otherwise use the Content.

 

Procedures for Claimed Copyright Infringement

We respect the intellectual property rights of others and we ask that you do the same. If you believe that your work has been copied in a way that constitutes copyright infringement, please provide our Legal and Compliance Team (email: **PRIVACY@ESTABLISHMENTLABS.COM**) with the following information:

  • an electronic or physical signature of the person authorised to act on behalf of the owner of the copyright interest;
  • a description of the copyrighted work that you claim has been infringed;
  • a description of where the material that you claim is infringing is located on the Site;
  • your address, telephone number, and email address;
  • a statement by you that you have a good faith belief that the disputed use is not authorized by the copyright owner, its agent, or the law;
  • a statement by you, made under penalty of perjury, that the above information in your notice is accurate and that you are the copyright owner or duly authorised to act on the copyright owner’s behalf.

 

Trademark Notice

All of the trademarks, service marks and logos displayed on this Site (the “Trademark(s)”) are registered and unregistered trademarks of ESTABLISHMENT LABS, its affiliates or third parties. Nothing contained in this Site should be construed as granting, by implication, estoppel or otherwise, any licence or right in and to the Trademarks without the express written permission of ESTABLISHMENT LABS or the applicable third party. Except as expressly provided in this Agreement, any use of the Trademarks found on the Site is strictly prohibited. Please note that the names of the companies and products mentioned on this Site may be trademarks of their respective owners. A complete list of ESTABLISHMENT LABS’ trademarks for each operating segment is provided below.

 

ESTABLISHMENT LABS Brands

 

Public and Unsolicited Information

This Site may provide opportunities to provide ESTABLISHMENT LABS feedback regarding this Site and our products and other unsolicited submissions (collectively, “Unsolicited Information”). You may only provide Unsolicited Information that meets the requirements of these Terms and Conditions. ESTABLISHMENT LABS and its employees do not accept or consider other unsolicited ideas, including ideas for new advertising campaigns, new promotions, new products or technologies, processes, materials, marketing plans or new product names. Please do not send any original creative artwork, samples, demos or other works. The sole purpose of this policy is to avoid potential misunderstandings or disputes when ESTABLISHMENT LABS’ products or marketing strategies might seem similar to ideas submitted to ESTABLISHMENT LABS. So, except under the circumstances described above relating to patented ideas or those for which you have filed a patent application, please do not send your unsolicited ideas to ESTABLISHMENT LABS or anyone at ESTABLISHMENT LABS.

If, despite our request that you not send us your ideas and materials, you still send them, and in the event that you post Public Information on our Site, all such Public Information and all such Unsolicited Information will be considered NON-CONFIDENTIAL and NON-PROPRIETARY, and ESTABLISHMENT LABS and its affiliates are free to use such information for any purpose and in any manner whatsoever.

This Site may present opportunities to post information to public areas of the Site, such as bulletin boards (collectively, “Public Areas”), or to send along comments and feedback (any such information provided, “Public Information”). Although ESTABLISHMENT LABS may, from time to time, monitor or review the information posted to the Public Areas of the Site, ESTABLISHMENT LABS is under no obligation to do so, and assumes no responsibility or liability arising from the Content of such Public Areas or the Site in general or for any error, defamation, libel, slander, omission, falsehood, obscenity, pornography, profanity, danger or inaccuracy contained in the Site. You are prohibited from posting or transmitting any unlawful, threatening, libellous, defamatory, obscene, inflammatory, pornographic or profane material or any material that could constitute or encourage conduct that would be considered a criminal offense, give rise to civil liability or otherwise violate the law. ESTABLISHMENT LABS will fully cooperate with any law enforcement authorities or court order requesting or directing ESTABLISHMENT LABS to disclose the identity of anyone posting any such material.

Children under the age of 18 should not submit any Public Information or Unsolicited Information containing personally identifiable data.

 

Links to Other Websites

This Agreement applies to this Site. This Site may frame or contain references or links to other ESTABLISHMENT LABS Websites (the “Other ESTABLISHMENT LABS Sites”). Please note that Other ESTABLISHMENT LABS Sites are governed by their specific Terms and Conditions and Privacy Policies. We recommend that you carefully read those documents upon your entry to those Other ESTABLISHMENT LABS Sites. If, however, those Other Establishment Labs Sites do not have their own specific Terms and Conditions and Privacy Policies, the ones on this Site apply.

 

No Framing Allowed

Elements of this Site are protected by copyright, trade dress, trademark, unfair competition and other laws, and may not be copied or imitated in whole or in part by any means, including, but not limited to, the use of framing, deep linking or mirrors. None of the Content for our Site may be retransmitted without the express written consent of ESTABLISHMENT LABS. If you are interested in linking to our Site, contact us for more information.

 

Dealings with Advertisers

Your correspondence or business dealings with, or participation in promotions of, advertisers found on or through the Site, including payment and delivery of related goods or services, and any other terms, conditions, warranties, or representations associated with such dealings are solely between you and such advertiser. You agree that we are neither responsible nor shall we be liable for loss or damage of any sort incurred as a result of any such dealings or as the result of the presence of such advertiser on the Site.

 

Account Registration

Some of the functions of this Site may require the creation of an account with us. As part of the registration process, visitors will select a User Name and Password, along with registration information, which must be accurate and updated. You may not select or use a User Name of another person with the intent to impersonate that person or use a User Name in which another person has rights without such person’s authorisation. Failure to comply with the above shall constitute a breach of this Agreement, which may result in immediate termination of your account. You agree to take reasonable measures to protect the security of your password.

You are responsible for all usage or activity on your account, including use of the account by any third party authorised by you to use your User Name and Password. You shall notify ESTABLISHMENT LABS of any known or suspected unauthorised use(s) of your account, or any known or suspected breach of security, including loss, theft or unauthorised disclosure of your password or any other relevant registration details provided.

 

Site Privacy Statement

Our Privacy Statement is available on this Site, and by accessing the Site, you are agreeing to be legally bound by the Privacy Policy. The Privacy Policy in its entirety is hereby incorporated into this Agreement by reference. To read our Privacy Policy, please click **HERE**.

 

Disclaimer of Warranties

The Site AND THE CONTENT ARE PROVIDED ON AN “AS IS”, “AS AVAILABLE” BASIS, WITHOUT WARRANTIES OF ANY KIND. THERE MAY BE DELAYS, OMISSIONS OR INACCURACIES IN THE CONTENT AND the Site. ESTABLISHMENT LABS AND ITS AFFILIATES DO NOT WARRANT THE ACCURACY, COMPLETENESS, TIMELINESS, NON-INFRINGEMENT, TITLE, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OF THE CONTENT OR the Site ITSELF, AND WE HEREBY DISCLAIM ANY SUCH EXPRESS OR IMPLIED WARRANTIES. ESTABLISHMENT LABS DOES NOT REPRESENT OR WARRANT THAT THE CONTENT OF this Site IS FREE OF VIRUSES, WORMS OR OTHER CODE THAT MAY MANIFEST CONTAMINATING OR DESTRUCTIVE PROPERTIES. BECAUSE SOME JURISDICTIONS DO NOT PERMIT THE EXCLUSION OF CERTAIN WARRANTIES, THESE EXCLUSIONS MAY NOT APPLY TO YOU.

 

Limitation of Liability

YOUR USE OF THIS SITE IS AT YOUR SOLE RISK. UNDER NO CIRCUMSTANCES SHALL ESTABLISHMENT LABS, ITS AFFILIATES OR ANY OF THEIR RESPECTIVE DIRECTORS, OFFICERS, EMPLOYEES OR AGENTS, BE LIABLE FOR ANY DIRECT OR INDIRECT LOSSES OR DAMAGES ARISING OUT OF OR IN CONNECTION WITH YOUR USE OF OR INABILITY TO USE THIS SITE, OR YOUR RELIANCE ON ANY CONTENT. THIS LIMITATION OF LIABILITY APPLIES TO ALL LOSSES AND DAMAGES OF ANY KIND WHATSOEVER, WHETHER DIRECT OR INDIRECT, GENERAL, SPECIAL, INCIDENTAL, CONSEQUENTIAL, EXEMPLARY OR OTHERWISE, INCLUDING WITHOUT LIMITATION, LOSS OF DATA, REVENUE OR PROFITS. THIS LIMITATION OF LIABILITY APPLIES WHETHER THE ALLEGED LIABILITY IS BASED ON CONTRACT, NEGLIGENCE, TORT, STRICT LIABILITY OR ANY OTHER BASIS AND EVEN IF AN AUTHORISED REPRESENTATIVE OF ESTABLISHMENT LABS OR ITS AFFILIATES HAS BEEN ADVISED OF OR SHOULD HAVE KNOWN OF THE POSSIBILITY OF SUCH DAMAGES.

SOME COUNTRIES DO NOT ALLOW THE EXCLUSION OF DAMAGES OR LIMITATION OF LIABILITY SET FORTH ABOVE, SO THIS LIMITATION OF LIABILITY MAY NOT APPLY TO YOU. IF ANY PART OF THIS LIMITATION OF LIABILITY IS FOUND TO BE INVALID OR UNENFORCEABLE FOR ANY REASON, THEN THE AGGREGATE LIABILITY OF ESTABLISHMENT LABS AND/OR ITS AFFILIATES UNDER SUCH CIRCUMSTANCES SHALL NOT EXCEED ONE HUNDRED ($100.00) US DOLLARS IN THE AGGREGATE. IF ANY REMEDY HEREUNDER IS DETERMINED TO HAVE FAILED ITS ESSENTIAL PURPOSE, ALL LIMITATIONS OF LIABILITY, DISCLAIMERS AND EXCLUSIONS OF WARRANTIES AND DAMAGES SET FORTH IN THIS AGREEMENT SHALL REMAIN IN EFFECT.

 

Forward-Looking Statements

This Site may from time to time contain certain forward-looking statements regarding ESTABLISHMENT LABS’ performance, including future revenues, products and income, or events or developments that ESTABLISHMENT LABS expects to occur or anticipates occurring in the future. All such statements are based upon current expectations of ESTABLISHMENT LABS and involve a number of business risks and uncertainties. Actual results could vary materially from anticipated results described, implied or projected in any forward-looking statement. Factors that could cause actual results to vary materially from any forward-looking statement include, but are not limited to: competitive factors; pricing and market share pressures; uncertainties of litigation; ESTABLISHMENT LABS’ ability to achieve sales and earnings forecasts, which are based on sales volume and product mix assumptions, to achieve its cost savings objectives and to achieve anticipated synergies and other cost savings in connection with acquisitions; changes in regional, national or foreign economic conditions; increases in energy costs: fluctuations in costs and availability or raw materials and in ESTABLISHMENT LABS’ ability to maintain favourable supplier arrangements and relationships; changes in interest or foreign currency exchange rates; delays in product introductions; and changes in healthcare or other governmental regulation; as well as other factors discussed in this Site in ESTABLISHMENT LABS’ filings with the Securities and Exchange Commission. We do not intend to update any forward-looking statements.

 

Indemnification

In the event that any legal action is taken resulting from (i) your use of the Content or Site, including your breach of the terms of this Agreement, or (ii) any Unsolicited Information provided by you, you agree to defend, indemnify, hold harmless and pay any reasonable legal and accounting fees without limitation incurred by ESTABLISHMENT LABS, its affiliates, its and their directors, officers, employees, agents, investors or licensors. ESTABLISHMENT LABS shall provide notice to you promptly of any such claim, suit or proceeding. ESTABLISHMENT LABS shall have the right, at its option and expense, to participate in the defence and/or settlement of any claim or action, or to assume the exclusive defence and control of any matter otherwise subject to indemnification by you without relieving your indemnification obligations. In no event shall you settle any suit or claim imposing any liability or other obligations on ESTABLISHMENT LABS without its prior written consent.

 

General

You are responsible for obtaining and maintaining all telephone, computer hardware and other equipment needed for access to and use of the Site and all charges related thereto. ESTABLISHMENT LABS reserves the right to alter or delete material from this Site at any time. This Site is controlled and operated by ESTABLISHMENT LABS Holdings Inc. from its offices within Costa Rica. Any claim relating to, and the use of, this Site are governed by the laws of Costa Rica. By using this Site, you consent to personal jurisdiction in Costa Rica, for any action arising out of or relating to this Site or your use of this Site. Such courts shall have exclusive jurisdiction over all such actions. The United Nations Convention on Contacts for the International Sale of Goods does not apply to this Agreement.

This Agreement constitutes the entire agreement between you and ESTABLISHMENT LABS with respect to your access to and/or use of this Site. Any claims arising in connection with your use of the Site or any Content must be brought within one (1) year of the date of the event giving rise to such action. All provisions of this Agreement pertaining to indemnification, disclaimer of warranties, limitation of liability and proprietary rights shall survive the termination of this Agreement for any reason. If any provision of this Agreement is invalid or unenforceable, the remaining provisions will continue in full force and effect, and the invalid or unenforceable provision will be deemed superseded by a valid enforceable provision that closely matches the intent of the original provision. The failure by us to exercise or enforce any right or provision under this Agreement shall not constitute a waiver of such right or provision. All rights not expressly granted herein are hereby reserved.

Reporting Hotline
Careers

ABOUT

PETER

CALDINI

President

PETER

CALDINI

President

Peter Caldini joined the Company as the President in August 2024.  Prior to joining in August, Peter worked as a consultant with the Company’s leadership team to identify efficiencies and cost savings. Before that, Peter was the Chief Executive Officer at Acreage Holdings, Inc., a publicly traded company, from December 2020 to June 2023. Prior to that, he was the Chief Executive Officer and a director at Bespoke Capital Acquisition Corp., a special purpose acquisition corporation, from June 2019 until December 2020. Prior to that, he held positions of increasing responsibility at Pfizer, Inc., including Regional President North America for Pfizer Consumer Healthcare from 2017 to 2019; Regional President EMEA of Pfizer Consumer Healthcare from 2016 to 2017, and leader of the Northern European cluster from 2015 to 2016. From 2009 to 2014, Peter held roles of increasing responsibility at Bayer Consumer Healthcare, including leading the Global Nutritionals Strategic Business Unit and running a sub-region of emerging markets in EMEA. And from 2002 to 2009, he held roles of increasing responsibility at Wyeth Consumer Healthcare in the US and Internationally. Peter received a Masters of International Economics and Management from Bocconi University in Milan, Italy, an MBA from Northeastern University and a BA, Political Science from Boston University.

Learn more about:

ABOUT

ROSS

MANSBACH
General Counsel & Chief Compliance Officer

ROSS

MANSBACH
General Counsel & Chief Compliance Officer

Ross Mansbach joined the company in August 2022 as the General Counsel and Chief Compliance Officer. He was previously at Avanos Medical, Inc., a publicly traded medical device company, where he held positions including Senior Vice President, Interim General Counsel and Corporate Secretary and Vice President, Deputy General Counsel and Corporate Secretary, between November 2014 and March 2022. Prior to that, Mr Mansbach held positions of increasing responsibility in the Legal Department at Kimberly-Clark Corporation for more than ten years. Earlier in his career, Mr Mansbach was a partner at the law firm of Powell Goldstein Frazer & Murphy, now known as Bryan Cave. He was also a judicial clerk for a United States District Court judge for the Northern District of Illinois. Mr Mansbach received his BA from Yale College and his JD from The University of Chicago.

Learn more about:

ABOUT

JEFF

EHRHARDT

SVP & General Manager – North America

JEFF

EHRHARDT

SVP & General Manager – North America

Mr. Ehrhardt joined the Establishment Labs leadership team in April of 2024 after a distinguished career in Plastic Surgery and Dermatology in the U.S. market.  He was most recently VP and General Manager of the U.S. Plastic Surgery and Regenerative Medicine business unit for Allergan Aesthetics, an Abbvie company.  In his 26 plus years at Allergan he held various senior leadership roles such as VP U.S. Commercial Operations, VP of Sales Plastic Surgery & Regenerative Medicine and VP of Sales and Marketing, U.S. Dermatology.  Notably, he was head of Dermatology Sales for the launch of Botox Cosmetic, acquisition and merger of Lifecell into the U.S. Plastic Surgery organization, acquisition and launch of Aczone®, an acne product, and the launch of the Inspira® line of breast implants.   In his role at Establishment Labs, he will be responsible for the commercialization of the Motiva® Femtech line of breast aesthetics devices in both the U.S. and Canada.   He holds undergraduate degrees in Finance and Marketing from the University of Cincinnati and an M.B.A. from Xavier University.

Learn more about:

ABOUT

PAUL

RODIO

Chief Operating Officer

PAUL

RODIO

Chief Operating Officer

Paul is a seasoned Operations Executive with over 30 years of global experience across supply chain, manufacturing and operations within Med Device, Consumer Packaged Goods and Industrial industries.

Paul joined Establishment Labs on 1 December 2022 from Cardinal Health, where he led the Medical Segment’s Global supply chain planning, procurement, deployment, service and repair, medical device reprocessing operations and key account CPFR as Senior Vice President Global Planning and Operations. Prior to that, he was Vice President Supply Chain, Contract Manufacturing for Medtronic and Covidien. Earlier in his career, he held positions of increasing responsibility at Newell Rubbermaid, Evenflo, Arthur Anderson LLP and Swagelok.

Learn more about:

ABOUT

ROSALYN

COLE D’INCELLI

SVP, Global Clinical, Medical & US Regulatory Affairs

ROSALYN

COLE D’INCELLI

SVP, Global Clinical, Medical & US Regulatory Affairs

Rosalyn d’Incelli has been a part of Establishment Labs® since May of 2020 as the company’s Head of Clinical and Medical Affairs, bringing to the company over 20 years of medical device experience. In this role, she drives global clinical and medical strategy and execution and leads US Regulatory Affairs. Prior to joining us, she was with Sientra Inc., for 11 years as the Vice President of Clinical and Medical Affairs. She was responsible for US PMA approval, Medical Education, PR, Publications and the company’s scientific content. She represented the company with FDA, media and medical education events and congresses. Preceding Sientra, Ms d’Incelli held similar roles with PMA approvals at Mentor/Johnson & Johnson and Inamed (now Allergan/AbbVie). She holds a BA in communication/market research from the University of California, Santa Barbara, and is board-certified in SoCRA and RAP.
Learn more about:

ABOUT

SALVADOR

DADA

Head of Special Projects

SALVADOR

DADA

Head of Special Projects

Mr Dada was one of the founding members of the company back in 2004. Salvador initially led the implementation of Establishment Labs® operations in Costa Rica and the successful certification of the Motiva Implants® product family by the European Union and other high-vigilance countries.

In February 2016, he was appointed as our Chief Operating Officer where he led the expansion of the operations to Brazil, Belgium and, in recent years, to several other European countries where direct commercial operations were launched. Due to health issues, he resigned from his position as COO and now serves as Head of Special Projects. Mr Dada served in various engineering roles at Allergan Medical from 2007 to 2009 and in a variety of production and manufacturing roles at Establishment Biotech, S.A. from 2004 to 2006.

He has an undergraduate and licentiate degree in Industrial Engineering from the University of Costa Rica.

Learn more about:

ABOUT

ROBERTO

DE MEZERVILLE

Chief Technology Officer

ROBERTO

DE MEZERVILLE

Chief Technology Officer

Since 2009, Roberto has risen through several positions in our company, in the areas of quality management, research, regulatory and clinical affairs, and has been our CTO heading Research, Development and Innovation since January 2018.

Roberto has led several impactful research projects that have been key to the science-based design of our Femtech technologies, and has authored peer-reviewed publications. From 2006 to 2009, served in various engineering and quality manager positions with Allergan Medical Costa Rica.

He has a bachelor’s degree in Business Administration from Universidad Interamericana de Costa Rica and a bachelor’s degree in Industrial Environmental Health and Safety Engineering from Instituto Tecnológico de Costa Rica.

Learn more about:

ABOUT

RAJ
DENHOY

Chief Financial Officer

RAJ

DENHOY

Chief Financial Officer

Raj has been part of Establishment Labs® since February 2021. Before his current role as Chief Financial Officer, he served as the company’s Head of Strategy and Investor Relations. Raj joined the company from Jefferies Group, LLC where he was a Managing Director and led the US medical device research team for eleven years, including coverage of Establishment Labs®.

He covered the medical device industry as an equity research analyst for over twenty years. Raj has an impressive academic portfolio, including a bachelor’s degree in biology from UC Berkeley, a master’s degree in Physiology from Georgetown University and an MBA from Cornell University.

Learn more about:

ABOUT

IVAN

BILIC

Senior Vice President of Commercial Operations – OUS

IVAN

BILIC

Senior Vice President of Commercial Operations – OUS

Mr. Bilic has been part of Establishment Labs since April 8, 2019, and is dedicated to advancing women’s health through innovative technology. His career highlights include roles as senior commercial director for European distribution markets, vice president for EMEA, and his current position as senior vice president for OUS. Notable accomplishments include restructuring the commercial function and transforming the German market. In his current role, Mr. Bilic strategically leads Establishment Labs’ commercial efforts, overseeing both the channel and direct markets and shaping B2B and B2B2C strategies for market leadership. He represents Establishment Labs in the non-U.S. plastic surgery market and drives innovative marketing approaches globally. Prior to joining Establishment Labs, he held key positions at Polytech and Allergan and holds a Master of Business Administration from Hult International Business School.

Learn more about:

ABOUT

ROBERT

LANGER

PhD

ROBERT

LANGER

PhD

Robert Langer is an Institute Professor at MIT (there are 13 Institute Professors at MIT; an Institute Professor is the highest honour awarded to a faculty member). His h-index of 232 is the highest of any engineer in history. He has over 1,130 issued and pending patents which have been licensed or sublicensed to over 300 companies. He served as Chair of the FDA’s SCIENCE BOARD (highest advisory board) from 1999-2002.  Langer is one of a very few individuals elected to the National Academy of Medicine, the National Academy of Engineering, the National Academy of Sciences and the National Academy of Inventors.  He is one of four living individuals to receive both the US National Medal of Science and the US National Medal of Technology and Innovation.  In 2015, Dr Langer received the Queen Elizabeth Prize for Engineering.  He has also received the Draper Prize (considered the engineering Nobel Prize), Albany Medical Center Prize, Wolf Prize for Chemistry, Millennium Technology Prize, Priestley Medal (highest award of the American Chemical Society),  Gairdner Prize, Kyoto Prize and the Lemelson-MIT Prize, for being “one of history’s most prolific inventors in medicine”. He holds 29 honorary doctorates including honorary degrees from Harvard and Yale.

ABOUT

PROF. MICHAEL

ATLAN

MD & PhD

PROF. MICHAEL

ATLAN

MD & PhD

Prof. Michael Atlan MD, Ph.D. is currently the chief of the Plastic and Reconstructive Surgery Department at TENON Hospital and a Professor at the Sorbonne Médecine Université.

His main interests are aesthetic breast surgery, breast reconstruction with ADM, free flaps for breast reconstruction, and breast cosmetic surgery (anatomic implants, fat grafting). His areas of expertise include breast implant surface, the evaluation of new devices in plastic surgery, and facial aesthetic surgery.

He is one of the founders of the CAMPUS CHAMPS ELYSEES.

ABOUT

ARDESHIR

BAYAT

MD & PhD

ARDESHIR

BAYAT

MD & PhD

Prof. Ardeshir Bayat is Director of the Medical Research Council Wound Healing Unit and professor at the University of Cape Town, Cape Town in South Africa. He is considered an expert in wound healing, cutaneous repair and skin scarring, with internationally recognised expertise in implant surface technology, fibrosis and capsular contracture. He trained as a surgeon-scientist with a PhD in molecular genetics of fibrosis. He has published extensively in peer-reviewed scientific literature (in excess of 500 articles to date). He is regularly an invited speaker at both national and international tissue repair conferences (over 600 conferences to date) and serves on the editorial boards of several journals.

His team have created and patented novel biomimetic surfaces and continue to work on developing models to understand the process of cell surface interaction/capsular fibrosis and its modulation related to implant surfaces. His investigative work has enabled translation of basic science to therapeutic developments of direct relevance to both cosmetic patients and industry.

ABOUT

BRIAN

KINNEY

MD & Eng

BRIAN

KINNEY

MD & Eng

Dr Brian M. Kinney is a Clinical Associate Professor of Plastic Surgery at the University of Southern California in Los Angeles and a reputable board-certified plastic surgeon. Dr Kinney has served as President of the Plastic Surgery Educational Foundation of the US (PSEF), Chair of the Board of Trustees of the American Society of Plastic Surgeons (ASPS), Deputy Secretary General of the International Confederation of Aesthetic, Plastic and Reconstructive Surgeons (IPRAS), Board member of the American Society for Aesthetic Plastic Surgery (ASAPS), part of the International Society of Aesthetic Plastic Surgeons (ISAPS), Co-founder and member of the board of directors of the International Society of Plastic Regenerative Surgery (ISPRES), as well as Chair and Medical Director of Thermi. Dr Kinney has one of the top plastic surgery practices in southern California for over 25 years and is also a staff member of many major hospitals in West Los Angeles, such as St. John’s Hospital and Health Center and Cedars-Sinai Medical Center. Dr Kinney earned his bachelor’s degree (Biomedical/Mechanical Engineering) and master’s degree (Mechanical/Electrical Engineering) after completing the Harvard/MIT Health Sciences and Technology programme. He then attended medical school at Tulane University and trained in general surgery and plastic surgery at UCLA in Los Angeles, CA, USA.

ABOUT

ARIKHA

MOSES

MD & PhD

ARIKHA

MOSES

MD & PhD

Arikha is an experienced medical device executive and entrepreneur, whose companies developed products that have been implanted in millions of patients worldwide. She was the founder and CEO of Galatea Surgical (now owned by Becton Dickinson), guiding the company from inception, through clinical studies and the commercial release of GalaFLEX© for soft tissue reinforcement. She was also the founder and CSO of TyRx (now Medtronic Infection Control), which commercialised antibiotic eluting products for the prevention of infection associated with indwelling devices. Over more than 20 years in the industry, Arikha has cultivated deep expertise in resorbable surgical products and the development of solutions to complications associated with implantable devices. Arikha is currently an investor and board member of several privately held medical companies and non-profit organisations. She has a PhD in Chemistry from Yale and a BA in Chemistry from Brandeis University.

ABOUT

DR MARCOS

SFORZA

MD

DR MARCOS

SFORZA

MD

Prof. Marcos Sforza, MD Marcos Sforza is one of the most renowned lecturers and researchers in the realm of plastic surgery. He is a Senior Professor of Plastic Surgery and regenerative medicine at the SESA University, Brazil, a Professor of Cosmetic Surgery at UNIFESO School of Medicine, responsible for the Elective Internship in Cosmetic Surgery in the UK and a Fellow of the Royal College of Surgeons of England. 

Prof. Sforza is a registered member of the International Society of Aesthetic Plastic Surgery – ISAPS, the Brazilian Society of Plastic Surgery, the American Society of Plastic Surgery and the American Society of Aesthetic Plastic Surgery. He has more than 100 peer-reviewed published papers and lectures all around the world as the world’s leading authority in nanosurfaced silicone breast implants. He is also the Editor in Chief of the Journal of Surgery and the Annal of Plastic and Reconstructive Surgery Journals.

ABOUT

DR ALEXANDRE

MUNHOZ

MD

DR ALEXANDRE

MUNHOZ

MD

Dr Alexandre Mendonça Munhoz, MD, PhD is Assistant Professor of Plastic Surgery, Breast Surgery Division of Plastic Surgery at University of São Paulo School of Medicine in Sao Paolo, Brazil, and a full member of the Brazilian Society of Plastic Surgery (SBCP). He participates as a guest member of the international consultants of Plastic and Reconstructive Surgery and Breast Journal since 2006.

In the period of 2010–2014, Dr Munhoz took over the role of a permanent member of the editorial board of the Annals of Plastic Surgery and the coordination of the National Commission of Breast Reconstruction of the Brazilian Society of Plastic Surgery.

Dr Munhoz currently has 27 scientific awards related to plastic surgery research, 145 published scientific papers, with 124 indexed in PubMed platform, 93 publications as a first author and in the area of aesthetic and reconstructive breast surgery, which resulted in about the 2967 citations with an H-Index of 29.

In 2013, he became Head of the Breast Reconstruction Department of the Cancer Institute of São Paulo (ICESP). In 2015, Dr Munhoz took over the Department of Plastic Surgery of the Moriah Hospital. In 2016, he was elected by American Society of Plastic Surgery (ASPS) as Associated Editor of Plastic and Reconstructive Surgery Global Open Journal. In 2022, Dr Munhoz became an international member of the American Society of Plastic Surgery (ASPS) and a full member of International Society of Aesthetic Plastic Surgery (ISAPS).

ABOUT

DR DENNIS

HAMMOND

MD

DR DENNIS

HAMMOND

MD

Dr Dennis Hammond, a board-certified plastic surgeon by the American Board of Plastic Surgery, is one of the world’s most recognised and respected authorities in breast aesthetic and reconstructive surgery. He is a member of and has served on numerous committees for the American Society of Plastic Surgeons (ASPS) as well as for the American Society for Aesthetic Plastic Surgery (ASAPS), and is a member of the prestigious American Association of Plastic Surgeons.

Dr Hammond has co-edited one of the most influential textbooks in plastic surgery along with his friend and colleague Dr Scott Spear from Georgetown University in Washington DC. He has authored many scientific papers, and serves as a reviewer for scientific articles for Aesthetic Plastic Surgery, Plastic and Reconstructive Surgery and the Journal of Aesthetic Surgery.

Dr Hammond wrote the “Atlas of Aesthetic Breast Surgery”, first published in 2009, a book which became a gold standard on how to perform new and innovative techniques for surgically and artistically augmenting, reshaping, lifting and reducing the breast.

ABOUT

DR NIAMH

CORDUFF

MD

DR NIAMH

CORDUFF

MD

Dr Niamh Corduff qualified from Charing Cross Medical School, the University of London, in 1984 and subsequently did her basic surgical training in the UK before emigrating to Australia in 1988. Dr Corduff completed her specialist plastic surgical training in Melbourne, Australia, and in 1993, became a Fellow of the Royal Australasian College of Surgeons. With more than 2 decades of experience, this Australian surgeon is a member and former president of the Australasian Society for Aesthetic Plastic Surgery and an honorary member of the Australian Society of Plastic Surgeons. Dr Corduff developed a special interest in breast surgery and since 2000 her surgical practice was focused solely on aesthetic and reconstructive breast surgery. She has published and lectured on aesthetic breast surgery both locally and internationally.

ABOUT

DR FEDERICO

MAYO

MD

DR FEDERICO

MAYO

MD

Born in Spain in 1967, Dr Mayo holds a degree in medicine and surgery from Universidad Complutense de Madrid, a doctorate in research skills from Universidad Complutense de Madrid and a medical specialty in plastic aesthetic and reconstructive surgery since 2001, recognised by the UK. He is a member of the General Medical Council, validated in Switzerland and has professional experience in Zurich and currently in Madrid. 

He is the author of chapters in specialty books, and his works have been published in renowned journals, such as Aesthetic Plastic Surgery and Plastic and Reconstructive Surgery. Dr Mayo is an active member of the scientific society, including the Sociedad Española de Cirugía Estética y Plástica, the Asociación Española De Cirugía Estética, the International Society of Aesthetic Plastic Surgery and the American Society of Plastic Surgery. He is a reviewer for the Aesthetic Plastic Surgery Journal and has patented ideas applicable in breast implant manufacturing. He has completed over 12,000 surgical interventions as primary surgeon and has implanted over 10,000 breast implants in more than 20 countries around the world as part of conferences, Masterclasses and other scientific events.

ABOUT

JEFFREY
BETTINGER
Global Head of People

Jeffrey Bettinger joined Establishment Labs® in November 2021 from Nu Skin, a global leader in beauty and wellness, where he served as the Chief People and Places Officer. In addition, he held a variety of executive and senior leadership roles in medical devices, financial services, pharmaceuticals, and engineering.

Some of his past employers are USAA, Petco, State Farm, Fluor, and Walmart. He has had the honor of receiving regional and national recognition for leadership development and culture transformation. Moreover, he has been published on a variety of human capital topics. Mr. Bettinger has an extensive academic background, starting with a bachelor’s degree in communication, a master’s degree in Organizational Communication and Educational Administration from Idaho State University, and a Master’s in Business Administration from Liberty University.

Learn more about: